Cart
sales@molnova.com
1-pentyl-1H-indole-3-carboxylic acid
CAS No. 727421-73-0
1-pentyl-1H-indole-3-carboxylic acid( —— )
Catalog No. M28432 CAS No. 727421-73-0
1-pentyl-1H-indole-3-carboxylic acid is a compound used as a molecular building block.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 101 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 174 | In Stock |
|
| 25MG | 288 | In Stock |
|
| 50MG | 384 | In Stock |
|
| 100MG | 539 | In Stock |
|
| 200MG | 710 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-pentyl-1H-indole-3-carboxylic acid
-
NoteResearch use only, not for human use.
-
Brief Description1-pentyl-1H-indole-3-carboxylic acid is a compound used as a molecular building block.
-
Description1-pentyl-1H-indole-3-carboxylic acid is a compound used as a molecular building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorE3 Ligase Ligand-Linker Conjugate
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number727421-73-0
-
Formula Weight231.295
-
Molecular FormulaC14H17NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCn1cc(C(O)=O)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
ASK1-IN-1
ASK1-IN-1 is an inhibitor of apoptosis signal-regulating kinase 1 which is a key mediator in the apoptotic and inflammatory cellular stress response with an IC50 of 21 nM in biochemica assays.
-
PF-03814735
PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
-
TMN355
TMN355 is a potent chemical inhibitor of cyclophilin A and reduces foam cell formation and cytokine secretion,and is used for atherosclerosis. Silencing cyclophilin A in THP-1 cells and human monocytes using siRNA or chemical inhibitor, TMN355 resulted in decrease in lipid uptake by 65-75% even after exposure to oxidized LDL.
